secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001171843-21-007467
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase Q3 revenue $7.9M up 80% YoY; nine-month net income $2.7M
------------------------------------------------------------------

- Q3 revenue $7.9M vs $3.9M YoY; nine-month revenue $22.1M vs $12.3M.
- Nine-month net income $2.7M ($0.04 EPS gain) vs $0.8M in 2020.
- Solésence beauty science nine-month revenue $13.4M, up 204% YoY, exceeding full-year 2020.
- Personal Care Ingredients revenue $5.3M (+28%); Advanced Materials $3.4M (-8%).
- Purchase orders in hand for $27M+; ~$10M applies to 2021 orders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184321007467/0001171843-21-007467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184321007467/f8k_110321.htm
  HTML page:      https://secwatch.observer/filing/0001171843-21-007467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer